These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23064191)

  • 1. Competition for organic anion transporters in chronic renal disease.
    Lowenstein J
    Kidney Int; 2012 Nov; 82(9):1033; author reply 1033. PubMed ID: 23064191
    [No Abstract]   [Full Text] [Related]  

  • 2. Uremic solutes from colon microbes.
    Meyer TW; Hostetter TH
    Kidney Int; 2012 May; 81(10):949-954. PubMed ID: 22318422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anglerfish and uremic toxins.
    Lowenstein J
    FASEB J; 2011 Jun; 25(6):1781-5. PubMed ID: 21622695
    [No Abstract]   [Full Text] [Related]  

  • 4. The kidney and uremic toxin removal: glomerulus or tubule?
    Masereeuw R; Mutsaers HA; Toyohara T; Abe T; Jhawar S; Sweet DH; Lowenstein J
    Semin Nephrol; 2014 Mar; 34(2):191-208. PubMed ID: 24780473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing transporters to clear uremic toxins.
    Moe OW
    J Am Soc Nephrol; 2009 Dec; 20(12):2483-4. PubMed ID: 19926890
    [No Abstract]   [Full Text] [Related]  

  • 6. Do we need new indicators of dialysis adequacy based on middle-molecule removal?
    Vanholder R; Eloot S; Van Biesen W
    Nat Clin Pract Nephrol; 2008 Apr; 4(4):174-5. PubMed ID: 18268526
    [No Abstract]   [Full Text] [Related]  

  • 7. [Medium-sized molecules and the process of uremic intoxication].
    Lutz W
    Pol Tyg Lek; 1976 Jul; 31(27):1173-6. PubMed ID: 951302
    [No Abstract]   [Full Text] [Related]  

  • 8. Disposition and clinical implications of protein-bound uremic toxins.
    Jansen J; Jankowski J; Gajjala PR; Wetzels JFM; Masereeuw R
    Clin Sci (Lond); 2017 Jul; 131(14):1631-1647. PubMed ID: 28667064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. History of sorbents in uremia.
    Winchester JF; Ronco C; Brady JA; Clemmer J; Muller TE; Davankov V; Tsyurupa M; Pavlova L; Pavlov M; Levin NW
    Contrib Nephrol; 2001; (133):131-9. PubMed ID: 11477746
    [No Abstract]   [Full Text] [Related]  

  • 10. The colon: an overlooked site for therapeutics in dialysis patients.
    Poesen R; Meijers B; Evenepoel P
    Semin Dial; 2013; 26(3):323-32. PubMed ID: 23458264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Uremic middle-molecule toxins and their removal in hemofiltration].
    Kazakov IV; Timokhov VS
    Urol Nefrol (Mosk); 1991; (1):67-73. PubMed ID: 1858215
    [No Abstract]   [Full Text] [Related]  

  • 12. Roles of organic anion transporters in the progression of chronic renal failure.
    Enomoto A; Niwa T
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S27-31. PubMed ID: 17976081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bench to bedside view of uremic toxins.
    Vanholder R; Baurmeister U; Brunet P; Cohen G; Glorieux G; Jankowski J;
    J Am Soc Nephrol; 2008 May; 19(5):863-70. PubMed ID: 18287557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual renal function: a paradigm shift.
    Lowenstein J; Grantham JJ
    Kidney Int; 2017 Mar; 91(3):561-565. PubMed ID: 28202171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fraction b 4-2: isolation, characterization and biological activities with reference to uremic polyneuropathy.
    Man NK; Cueille G; Faguer P; Boudet J; Pierrat D; Zingraff J; Sausse A; Funck-Brentano JL
    Adv Exp Med Biol; 1987; 223():135-40. PubMed ID: 3447428
    [No Abstract]   [Full Text] [Related]  

  • 16. Middle molecules re-examined.
    Henderson LW
    Nephron; 1978; 22(1-3):146-52. PubMed ID: 745634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of small, middle, and large molecular weight substances in a dual filtration artificial kidney.
    Smeby LC; Jörstad S; Wideröe TE; Svartaas TM
    Artif Organs; 1981; 4 Suppl():104-9. PubMed ID: 7295075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adequate dialysis].
    Maduell Canals F
    Nefrologia; 2002; 22(2):111-34. PubMed ID: 12085413
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metabolic anomaly and uremic toxins in chronic renal insufficiency].
    Ueda Y
    Nihon Rinsho; 1974 Mar; 32(3):446-8. PubMed ID: 4859022
    [No Abstract]   [Full Text] [Related]  

  • 20. Separation and characterization of uremic metabolites in biologic fluids: a screening approach to the definition of uremic toxins.
    Gordon A; Berström J; Fürst P; Zimmerman L
    Kidney Int Suppl; 1975 Jan; (2):45-51. PubMed ID: 1057692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.